QQQ   279.79 (-0.67%)
AAPL   140.68 (-1.56%)
MSFT   243.56 (-0.64%)
META   113.44 (-0.60%)
GOOGL   95.39 (-1.64%)
AMZN   87.74 (-0.58%)
TSLA   173.19 (-3.69%)
NVDA   158.52 (-0.84%)
NIO   12.36 (-6.65%)
BABA   87.96 (-3.82%)
AMD   70.05 (-0.31%)
T   19.33 (+0.83%)
MU   53.48 (-0.37%)
CGC   3.37 (-6.65%)
F   13.26 (-0.15%)
GE   85.32 (+0.05%)
DIS   91.84 (-0.49%)
AMC   6.57 (-2.67%)
PYPL   72.13 (-0.14%)
PFE   50.36 (+1.31%)
NFLX   304.06 (-0.49%)
QQQ   279.79 (-0.67%)
AAPL   140.68 (-1.56%)
MSFT   243.56 (-0.64%)
META   113.44 (-0.60%)
GOOGL   95.39 (-1.64%)
AMZN   87.74 (-0.58%)
TSLA   173.19 (-3.69%)
NVDA   158.52 (-0.84%)
NIO   12.36 (-6.65%)
BABA   87.96 (-3.82%)
AMD   70.05 (-0.31%)
T   19.33 (+0.83%)
MU   53.48 (-0.37%)
CGC   3.37 (-6.65%)
F   13.26 (-0.15%)
GE   85.32 (+0.05%)
DIS   91.84 (-0.49%)
AMC   6.57 (-2.67%)
PYPL   72.13 (-0.14%)
PFE   50.36 (+1.31%)
NFLX   304.06 (-0.49%)
QQQ   279.79 (-0.67%)
AAPL   140.68 (-1.56%)
MSFT   243.56 (-0.64%)
META   113.44 (-0.60%)
GOOGL   95.39 (-1.64%)
AMZN   87.74 (-0.58%)
TSLA   173.19 (-3.69%)
NVDA   158.52 (-0.84%)
NIO   12.36 (-6.65%)
BABA   87.96 (-3.82%)
AMD   70.05 (-0.31%)
T   19.33 (+0.83%)
MU   53.48 (-0.37%)
CGC   3.37 (-6.65%)
F   13.26 (-0.15%)
GE   85.32 (+0.05%)
DIS   91.84 (-0.49%)
AMC   6.57 (-2.67%)
PYPL   72.13 (-0.14%)
PFE   50.36 (+1.31%)
NFLX   304.06 (-0.49%)
QQQ   279.79 (-0.67%)
AAPL   140.68 (-1.56%)
MSFT   243.56 (-0.64%)
META   113.44 (-0.60%)
GOOGL   95.39 (-1.64%)
AMZN   87.74 (-0.58%)
TSLA   173.19 (-3.69%)
NVDA   158.52 (-0.84%)
NIO   12.36 (-6.65%)
BABA   87.96 (-3.82%)
AMD   70.05 (-0.31%)
T   19.33 (+0.83%)
MU   53.48 (-0.37%)
CGC   3.37 (-6.65%)
F   13.26 (-0.15%)
GE   85.32 (+0.05%)
DIS   91.84 (-0.49%)
AMC   6.57 (-2.67%)
PYPL   72.13 (-0.14%)
PFE   50.36 (+1.31%)
NFLX   304.06 (-0.49%)
NASDAQ:NEOG

Neogen - NEOG Stock Forecast, Price & News

$15.49
+0.01 (+0.06%)
(As of 12/7/2022 11:28 AM ET)
Add
Compare
Today's Range
$15.47
$15.79
50-Day Range
$10.79
$16.56
52-Week Range
$10.49
$47.80
Volume
64,297 shs
Average Volume
3.08 million shs
Market Capitalization
$1.67 billion
P/E Ratio
45.56
Dividend Yield
N/A
Price Target
$14.00

Neogen MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
9.6% Downside
$14.00 Price Target
Short Interest
Healthy
13.33% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$502,220 Bought Last Quarter
Proj. Earnings Growth
-52.54%
From $0.59 to $0.28 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars

Medical Sector

817th out of 1,023 stocks

Diagnostic Substances Industry

9th out of 15 stocks

NEOG stock logo

About Neogen (NASDAQ:NEOG) Stock

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Stock News Headlines

Neogen, FFA Announce 2023 Sponsorship Agreement
Neogen Launches Ready-To-Use Chemiluminescent Substrate
Neogen (NEOG) Q1 2023 Earnings Call Transcript
Neogen: A Mess, Appears Priced In
Recap: Neogen Q1 Earnings
Neogen 1Q Profit Drops After Booking Acquisition Costs
Neogen Corporation (NEOG) Q1 2023 Earnings Call Transcript
See More Headlines
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

NEOG Company Calendar

Last Earnings
9/27/2022
Today
12/07/2022
Next Earnings (Estimated)
12/20/2022
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:NEOG
CUSIP
64049110
Employees
1,039
Year Founded
1982

Price Target and Rating

Average Stock Price Forecast
$14.00
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
-9.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$48.31 million
Pretax Margin
8.50%

Debt

Sales & Book Value

Annual Sales
$527.16 million
Cash Flow
$0.83 per share
Book Value
$8.23 per share

Miscellaneous

Free Float
107,051,000
Market Cap
$1.67 billion
Optionable
Optionable
Beta
0.78

Social Links


Key Executives

  • Mr. John Edward Adent (Age 54)
    Pres, CEO & Director
    Comp: $1.39M
  • Mr. Steven J. QuinlanMr. Steven J. Quinlan (Age 60)
    VP & CFO
    Comp: $602.85k
  • Mr. Douglas E. Jones (Age 52)
    COO & VP
    Comp: $692.16k
  • Sarah Demey
    Admin. Mang.
  • Ms. Amy M. Rocklin Ph.D. (Age 50)
    VP, Gen. Counsel & Corp. Sec.
  • Ms. Julie A. Mann (Age 57)
    VP & Chief HR Officer













NEOG Stock - Frequently Asked Questions

Should I buy or sell Neogen stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NEOG shares.
View NEOG analyst ratings
or view top-rated stocks.

What is Neogen's stock price forecast for 2023?

2 analysts have issued twelve-month price targets for Neogen's stock. Their NEOG share price forecasts range from $14.00 to $14.00. On average, they predict the company's stock price to reach $14.00 in the next twelve months. This suggests that the stock has a possible downside of 9.6%.
View analysts price targets for NEOG
or view top-rated stocks among Wall Street analysts.

How have NEOG shares performed in 2022?

Neogen's stock was trading at $45.41 at the start of the year. Since then, NEOG stock has decreased by 65.9% and is now trading at $15.48.
View the best growth stocks for 2022 here
.

When is Neogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 20th 2022.
View our NEOG earnings forecast
.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) posted its earnings results on Tuesday, September, 27th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by $0.01. The firm earned $132.35 million during the quarter, compared to analysts' expectations of $135.75 million. Neogen had a trailing twelve-month return on equity of 7.60% and a net margin of 6.86%.

When did Neogen's stock split?

Neogen shares split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly minted shares were distributed to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

Who are Neogen's major shareholders?

Neogen's stock is owned by many different institutional and retail investors. Top institutional investors include Jane Street Group LLC (0.00%) and Citadel Advisors LLC (0.00%). Insiders that own company stock include Bruce Papesh, Darci L Vetter, Douglas Edward Jones, James L Herbert, James P Tobin, Jason Warren Lilly, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm.
View institutional ownership trends
.

How do I buy shares of Neogen?

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $15.48.

How much money does Neogen make?

Neogen (NASDAQ:NEOG) has a market capitalization of $1.67 billion and generates $527.16 million in revenue each year. The company earns $48.31 million in net income (profit) each year or $0.34 on an earnings per share basis.

How many employees does Neogen have?

The company employs 1,039 workers across the globe.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The official website for the company is www.neogen.com. The company can be reached via phone at (517) 372-9200, via email at ir@neogen.com, or via fax at 517-372-2006.

This page (NASDAQ:NEOG) was last updated on 12/7/2022 by MarketBeat.com Staff